Literature DB >> 14479461

Effect of methyldopa in carcinoid disease.

G I NICHOLSON, R O IRVINE.   

Abstract

Entities:  

Keywords:  DOPA/related compounds; MALIGNANT CARCINOID SYNDROME/therapy

Mesh：

Substances：

Year:  1962        PMID： 14479461      PMCID： PMC1926410          DOI： 10.1136/bmj.2.5310.961

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  [On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].

Authors:  U C DUBACH; A BLUMBERG
Journal:  Klin Wochenschr       Date:  1961-09-15

2.  Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.

Authors:  R B DAVIS; C S ALEXANDER; A ADICOFF
Journal:  Metabolism       Date:  1961-12       Impact factor: 8.694

3.  Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.

Authors:  F J COLLINI
Journal:  N Engl J Med       Date:  1961-05-11       Impact factor: 91.245

4.  Paper chromatography of urinary indoles.

Authors:  J B JEPSON
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

5.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

6.  The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity.

Authors:  E BULBRING; R C LIN
Journal:  J Physiol       Date:  1958-03-11       Impact factor: 5.182

7.  Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.

Authors:  T L SOURKES
Journal:  Arch Biochem Biophys       Date:  1954-08       Impact factor: 4.013

8.  The effect of a serotonin antagonist (UML 491) in carcinoid disease.

Authors:  W S PEART; J I ROBERTSON
Journal:  Lancet       Date:  1961-11-25       Impact factor: 79.321

9.  A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.

Authors:  N R NOBLE
Journal:  Med J Aust       Date:  1961-10-07       Impact factor: 7.738

10.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.